These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 18714848)

  • 1. Interval cancers in the beginning years of the breast cancer screening programme in the Belgian province of Limburg.
    Kellen E; Putte GV; Van Steen A; Cloes E; Lousbergh D; Buntinx F; Van Limbergen E
    Acta Clin Belg; 2008; 63(3):179-84. PubMed ID: 18714848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
    Lynge E
    APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-specific interval breast cancers in New South Wales and meta-analysis of studies of women aged 40-49 years.
    Taylor R; Page A; Bampton D; Estoesta J; Rickard M
    J Med Screen; 2004; 11(4):199-206. PubMed ID: 15563775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammography screening in the county of Fyn. November 1993-December 1999.
    Njor SH; Olsen AH; Bellstrøm T; Dyreborg U; Bak M; Axelsson C; Graversen HP; Schwartz W; Lynge E
    APMIS Suppl; 2003; (110):1-33. PubMed ID: 12739252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring interval cancers in an Australian mammographic screening programme.
    Kavanagh AM; Mitchell H; Farrugia H; Giles GG
    J Med Screen; 1999; 6(3):139-43. PubMed ID: 10572844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Number and characteristics of breast cancer cases diagnosed in four periods in the screening interval of a biennial population-based screening programme.
    Hofvind S; Bjurstam N; Sørum R; Bjørndal H; Thoresen S; Skaane P
    J Med Screen; 2006; 13(4):192-6. PubMed ID: 17217608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nationwide breast cancer screening fully accomplished; results from the implementation phase 1990-1997. National Evaluation Team for Breast Cancer Screening].
    Ned Tijdschr Geneeskd; 2000 Jun; 144(23):1124-9. PubMed ID: 10876708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
    Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
    Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interval cancers in the Dutch breast cancer screening programme.
    Fracheboud J; de Koning HJ; Beemsterboer PM; Boer R; Verbeek AL; Hendriks JH; van Ineveld BM; Broeders MJ; de Bruyn AE; van der Maas PJ
    Br J Cancer; 1999 Nov; 81(5):912-7. PubMed ID: 10555768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of interval breast cancers after 650,000 negative mammographies in 13 Italian health districts.
    Bucchi L; Ravaioli A; Foca F; Colamartini A; Falcini F; Naldoni C;
    J Med Screen; 2008; 15(1):30-5. PubMed ID: 18416953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interval cancer incidence and episode sensitivity in the Norrbotten Mammography Screening Programme, Sweden.
    Bordás P; Jonsson H; Nyström L; Lenner P
    J Med Screen; 2009; 16(1):39-45. PubMed ID: 19349530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rising incidence of breast cancer after completion of the first prevalent round of the breast cancer screening programme.
    Schouten LJ; de Rijke JM; Huveneers JA; Verbeek AL
    J Med Screen; 2002; 9(3):120-4. PubMed ID: 12370323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction in hormone replacement therapy use and declining breast cancer incidence in the Belgian province of Limburg.
    Vankrunkelsven P; Kellen E; Lousbergh D; Cloes E; Op de Beeck L; Faes C; Bruckers L; Mertens R; Coebergh JW; Van Leeuwen FE; Buntinx F
    Breast Cancer Res Treat; 2009 Nov; 118(2):425-32. PubMed ID: 19238536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of invasive breast cancer and ductal carcinoma in situ in a screening program by age: should older women continue screening?
    Erbas B; Amos A; Fletcher A; Kavanagh AM; Gertig DM
    Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1569-73. PubMed ID: 15466971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interval cancer rates in the Irish national breast screening programme.
    O'Brien KM; Dwane F; Kelleher T; Sharp L; Comber H
    J Med Screen; 2015 Sep; 22(3):136-43. PubMed ID: 25917389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interval breast cancers in New South Wales, Australia, and comparisons with trials and other mammographic screening programmes.
    Taylor R; Supramaniam R; Rickard M; Estoesta J; Moreira C
    J Med Screen; 2002; 9(1):20-5. PubMed ID: 11943793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of clinical-pathological characteristics between symptomatic and interval breast cancer.
    Meshkat B; Prichard RS; Al-Hilli Z; Bass GA; Quinn C; O'Doherty A; Rothwell J; Geraghty J; Evoy D; McDermott EW
    Breast; 2015 Jun; 24(3):278-82. PubMed ID: 25771080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Balancing sensitivity and specificity: sixteen year's of experience from the mammography screening programme in Copenhagen, Denmark.
    Utzon-Frank N; Vejborg I; von Euler-Chelpin M; Lynge E
    Cancer Epidemiol; 2011 Oct; 35(5):393-8. PubMed ID: 21239242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urban-rural differences in the management of screen-detected invasive breast cancer and ductal carcinoma in situ in victoria.
    Kok DL; Chang JH; Erbas B; Fletcher A; Kavanagh AM; Henderson MA; Gertig DM
    ANZ J Surg; 2006 Nov; 76(11):996-1001. PubMed ID: 17054549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interval breast cancers in the Screening Mammography Program of British Columbia: analysis and classification.
    Burhenne HJ; Burhenne LW; Goldberg F; Hislop TG; Worth AJ; Rebbeck PM; Kan L
    AJR Am J Roentgenol; 1994 May; 162(5):1067-71; discussion 1072-5. PubMed ID: 8165983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.